Kei Takenaka

Distribution of erlotinib in rash and normal skin in cancer patients receiving erlotinib visualized by matrix assisted laser desorption/ionization mass spectrometry imaging

Meiko Nishimura, Mitsuhiro Hayashi, Yu Mizutani et al. · Oncotarget · 2018 · 19 citations · Full text

Medicine, Dermatology, Pharmacology +13

The combination of HLA-B*15:01 and DRB1*15:01 is associated with gemcitabine plus erlotinib-induced interstitial lung disease in patients with advanced pancreatic cancer

Meiko Nishimura, Masanori Toyoda, Kei Takenaka et al. · Cancer Chemotherapy and Pharmacology · 2016 · 17 citations · Full text

Life Sciences, Immunology, Oncology +17

Adapalene Gel 0.1% Versus Placebo as Prophylaxis for Anti-Epidermal Growth Factor Receptor-Induced Acne-Like Rash: A Randomized Left-Right Comparative Evaluation (APPEARANCE)

Naoko Chayahara, Toru Mukohara, Motoko Tachihara et al. · The Oncologist · 2019 · 14 citations · Full text

Medicine, Dermatology, Pharmacology +14

Invasive Scopulariopsis alboflavescens infection in patient with acute myeloid leukemia

Keiji Kurata, Sho Nishimura, Hiroya Ichikawa et al. · International Journal of Hematology · 2018 · 11 citations

Life Sciences, Microbiology, Oncology +4

Relationship between PDGFR expression and the response to pazopanib in intimal sarcoma of the pulmonary artery: A case report

Satoshi Sai, Yoshinori Imamura, Naomi Kiyota et al. · Molecular and Clinical Oncology · 2020 · 11 citations · Full text

Medicine, Oncology, Pharmacology +17